Advertisement Pharmaceutical Business review - Page 256 of 5278 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 24, 2026

Haisco and Nuvectis sign licensing deal for two drugs

Haisco Pharmaceutical Group has signed an exclusive licensing agreement granting US-based biotechnology company Nuvectis rights for two drug candidates in oncology and complement indications.

Continue
HSK42360 is under evaluation in a Phase I clinical trial in China. Credit: Miyao / Shutterstock.com.
June 23, 2026

Genprex’s Reqorsa combo secures Canadian patent for lung cancer

Genprex is conducting the Acclaim-3 Phase I/II clinical trial, assessing the combination of Reqorsa and Genentech’s Tecentriq. Credit: AnnaStills / Shutterstock.com.
June 22, 2026

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Following the conclusion of the deal, Sun Pharma will acquire full ownership and control of Innovcare Lifesciences. Credit: Nils Versemann / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Lilly and BioArctic sign deal to develop neurodegenerative therapy
  2. Japan approves Sanofi’s Sarclisa combo for MM treatment
  3. Voro and Alloy partner on tumour-selective TCE therapeutics
  4. Biogen to acquire RayThera for up to $1bn
  5. Jazz and AbCellera sign deal for T-cell engagers in solid tumours

PRESS RELEASES

Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C
Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C
Pharmaceutical Business Review
Redefining Safety, Efficiency, and Sustainability: SCHOTT Pharma Launches Next-Generation Polymer Syringe System
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography